Tag Directory / HEALTHCAREFINANCE     showing 1–9 of 9

for: Saturday, March 07, 2026



Eli Lilly's new program aims to boost employer coverage of GLP-1s / Endpoints

Shelby Livingston / endpoints - With insurance coverage of weight loss medications stalled, Eli Lilly has developed a program to give employers another way to pay for their workers' GLP-1 treatments. The pharma giant on Thursday announced the launch of ...

#obesity #healthcare #pharmaceuticals #drugpricing #elililly #weightloss #healthcarefinance

GLP-1 medication changes may support long-term weight management

16 hrs / medicalxpress

Wegovy may have highest 'eye stroke' and sight loss risk among semaglutide GLP-1 agonists

17 hrs / medicalxpress

2018 to 2025 saw rise in GLP-1 receptor agonist Rx for bariatric surgery-eligible patients

18 hrs / medicalxpress

Carrum Health teams up with Virta Health on a comprehensive weight loss solution

22 hrs / fiercehealthcare

Ascletis touts GLP-1 quarterly dosing data; Mineralys apnea Phase 2 misses

24 hrs / endpoints / ENDPOINTS

Mouse brain study reveals why blockbuster weight-loss drugs may work differently in females and males

34 hrs / medicalxpress

Digital nudges help GLP-1 users: Stanford

42 hrs / beckershospitalreview / Giles Bruce

Hims & Hers makes deal with Novo Nordisk as it shifts obesity strategy

46 hrs / fiercehealthcare

10 drugs poised to be global best-sellers in 2030

47 hrs / beckershospitalreview / Paige Twenter

AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China

2 days / endpoints / ENDPOINTS

Amazon Pharmacy expands Zepbound access

2 days / beckershospitalreview / Ella Jeffries

Hims agrees to limit compounding, ending feud with Novo Nordisk

2 days / endpoints / Shelby Livingston

Novo, Hims strike GLP-1 deal after legal feud

2 days / beckershospitalreview / Ella Jeffries

Roche, Zealand Pharma Obesity Drug Meets Clinical Trial’s Weight Loss Goals, But Can It Compete?

2 days / medcitynews / Frank Vinluan

Lilly Employer Connect Adds Flexibility for Employers But Isn’t Revolutionary, Expert Says

5 days / medcitynews / Marissa Plescia

Eli Lilly's new program aims to boost employer coverage of GLP-1s

5 days / endpoints / Shelby Livingston

Saturday, March 7, 2026, 10:21 pm / permalink 20341 / 16 stories in 3 days


Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient / Fierce

fiercehealthcare - A recent claims data analysis shows the 11% of people with multiple chronic conditions are behind 52% of inpatient admissions and about a third of outpatient visits. Their projected increases and unfavorable payer mix spell trouble for health systems' bot…

#healthcare #publichealth #hospitaloperations #healthcarefinance

11% of US population accounts for 52% of admissions: Vizient

6 days / beckershospitalreview / Paige Twenter

Patients with multiple chronic diseases are a looming threat to health systems' financials: Vizient

7 days / fiercehealthcare

Saturday, March 7, 2026, 10:21 pm / permalink 20340 / 2 stories in 3 days


Elizabeth McKenna: New Cancer Grand Challenges Teams Announced / OncoDaily

oncodaily - Elizabeth McKenna, Executive Editor of Cancer Discovery, shared a post on X: “The new Cancer Grand Challenges teams have just been announced! Read about the teams tackling cancer avoidance, mechanisms […]

#healthcare #biotech #drugdevelopment #oncology #healthcarefinance #cancerresearch #researchfunding

Accelerating Cancer Immunotherapy: Parker Institute & ASCO Launch Young Investigator Award

9 hrs / oncodaily

Douglas R. Lowy, MD, FAACR, and John T. Schiller, PhD, FAACR, Honored with the 2026 Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research

30 hrs / aacr / Julia DeMalto

Shared patterns of dysregulated gene expression across squamous cell carcinomas unveil predictors for prognosis and drug sensitivity

39 hrs / nature

Hidden metabolism found operating inside the cell nucleus

39 hrs / sciencedaily

Immune Pathways Help Identify Patients with Cancer and HIV Most Likely to Experience Reservoir Decay with Anti-PD1 Therapy

2 days / esmo

Study finds no evidence that prostate cancer drugs interact with anticoagulants to increase bleeding, clotting risks

2 days / medicalxpress

UK cancer death rates down to their lowest level on record

2 days / cancerresearchuk / Tim Gunn

OncoGrants Weekly: Top 10 OncoGrants to Apply for in 2026: Deadlines from March to June

2 days / oncodaily

A multicenter retrospective study of plasma d‑dimer levels for evaluating treatment response in multiple myeloma

2 days / nature

Prescription‑dose stratification improves deep learning‑based VMAT dose prediction in locally advanced NSCLC

2 days / nature

Gian Paolo Andreoletti: What If Cancer Originated Primarily From Systemic Metabolism?

2 days / oncodaily

Stephen Williams: Proud to Serve as Global PI for SunRISe-2 Trial

2 days / oncodaily

Binay Shah: 2nd Annual Binaytara Oklahoma Thoracic Oncology Conference

2 days / oncodaily

Sheraz Azhar: OncsCare Shortlisted for Medilink Midlands Business Awards 2026

2 days / oncodaily

Anton Safonov: Germline-Somatic Interactions Predict Treatment Resistance in Breast Cancer

2 days / oncodaily

Patrick Hwu: Why Some Cancer Cells Evade the Immune System During Early Spread

2 days / oncodaily

Vivek Subbiah: Commentary on Australia’s MoST Program

2 days / oncodaily

David C. Michael: How Epigenetics Shapes Cancer Beyond DNA Mutations

2 days / oncodaily

Samuel Stevens: Australian Oncologist Perspectives on Time Toxicity

2 days / oncodaily

International Women’s Day Highlights 2026: Honoring Women in Oncology

2 days / oncodaily

Ruben Mesa: Clinical and Translational Research Award Winners at Myeloid Malignancy Workshop

2 days / oncodaily

Joanna Metzner-Sadurski Highlights Key Takeaways from ASCO CoP Health Policy Webinar

2 days / oncodaily

ESTRO Issues New Guidance on IMRT and IGRT for Rectal Cancer – Radiotherapy and Oncology

2 days / oncodaily

Jeff Hanna Appointed Co-opted Board Member at UK Oncology Nursing Society

2 days / oncodaily

Emily Touloukian Joins Leaders Addressing Access to Cancer Care at ASCO Council Meeting

2 days / oncodaily

Jia Jenny Liu Shares Takeaways from APOS 2026 on the Future of Precision Oncology

2 days / oncodaily

Arturo LoAIza-Bonilla: AI in Lung Cancer Care at New York Lung Cancer Foundation Summit

2 days / oncodaily

Jemma Longley Returns to Teach Immunotherapy at The Institute of Cancer Research

2 days / oncodaily

Rahul Gosain Reviews Treatment Strategies for Triple Negative Breast Cancer

2 days / oncodaily

Ursula Catena Presents Study on Fertility-Preserving Treatment in Endometrial Disease

2 days / oncodaily

Ola Khorshid Leads Discussion on Global Health and Lung Cancer Disparities

2 days / oncodaily

Giuseppe Curigliano: New Therapies and the Role of Oncology Congresses – The Breast Friends Podcast

2 days / oncodaily

Countdown to the GCOS26 Champions League – International Cardio-Oncology Society

2 days / oncodaily

Alexandra Pons Riverola Shares Key Insights on Collaboration Between Cardiologists and Oncologists

2 days / oncodaily

Felipe Couñago: Global Assessment of Radiotherapy Access Gap and Future Needs

2 days / oncodaily

Rishabh Jain Explores RB1 Loss as a Driver of CDK4/6 Resistance in BRCA2 Breast Cancer

2 days / oncodaily

Wafik S. El-Deiry: Discussed Breast Cancer Stem-Like Cells at MIT Seminar

2 days / oncodaily

Daniel Stover: Multidisciplinary Breast Cancer Symposium at UChicago

2 days / oncodaily

Christopher Jackson: Defending Champion Title in the Oncologists’ Fitness Challenge

2 days / oncodaily

Preventing breast cancer resistance to CDK4/6 inhibitors using genomic findings

3 days / medicalxpress

Kim Curseen Named AAHPM’s Board President for 2026–2027 – AAHPM

3 days / oncodaily

Enrique Soto Pérez de Celis and the Future of Supportive Oncology at MASCC

3 days / oncodaily

Oncology This Two Weeks: OncoDaily Weekly Feb 23 – March 8, 2026

3 days / oncodaily

New Trial Seeks to Improve Sharing of Genetic Colorectal Cancer Risks – Alliance for Clinical Trials in Oncology

3 days / oncodaily

Sendurai Mani: A Successful Launch of the Hallmarks of Cancer Virtual Seminar Series

3 days / oncodaily

What pet cats can tell us about human cancer

3 days / theconversation / Geoffrey Wood, Professor, Co-Director, Institute for Comparative Cancer Investigation, University of

Tracey O’Brien: Faces of Some of the Extraordinary Women Helping to Prevent and Treat Cancer in NSW

3 days / oncodaily

Benny Johnson is Now The Executive Medical Director at Agenus

3 days / oncodaily

Jasmine Kamboj: How Showing Up And Engaging Is The First Step Of Leadership?

3 days / oncodaily

Angela Lamarca Celebrates ENETS Centre of Excellence Recognition for Fundación Jiménez Díaz

3 days / oncodaily

Rihab Melliti: An Advanced Course from ESMO for Patients With Advanced HR+/HER2− Breast Cancer

3 days / oncodaily

Bishal Gyawali Promotes ESMO Leadership Award as Pathway to Global Oncology Training

3 days / oncodaily

Giulia Madamombe: Presenting a Work at the 24th BTOG Annual Conference

3 days / oncodaily

International Women’s Day 2026: Championing women in cancer research

3 days / cancerresearchuk / Sophie Wedekind

Targeting erythroid progenitor cell metabolism to enhance cancer immunotherapy

3 days / nature

Performance of breast cancer risk prediction algorithms across mammography systems in the UK screening programme

3 days / nature

Alicia Zhou: How Open Data Could Accelerate Immunotherapy Discoveries

3 days / oncodaily

Lorenzo de la Rica: Cancer Grand Challenges Announces Five New Global Teams with £100M Investment

3 days / oncodaily

Yelena Janjigian and Norah Lewin Join NBC’s Saturday TODAY to Discuss Cycle for Survival’s 20th Anniversary

3 days / oncodaily

Smita Krishnaswamy: Proud to be Part of the Newly Funded CRUK Cancer Grand Challenge Team

3 days / oncodaily

Elizabeth C. Miller: Raised Over $416K for Pediatric Cancer Research

3 days / oncodaily

Pediatric Cancer Research Foundation: Recognizing 2026 Grant Recipients Advancing Childhood Cancer Research

3 days / oncodaily

Global Partners Unite to Fund High-Risk, High-Reward Cancer Science – Cancer Grand Challenges

5 days / oncodaily

Elizabeth McKenna: New Cancer Grand Challenges Teams Announced

5 days / oncodaily

Manju George: Joining the REWIRE CAN Team at Cancer Grand Challenges 2026

5 days / oncodaily

Congratulations to Karuna Ganesh and Team for Receiving the Cancer Grand Challenges Grant – MSKCC

6 days / oncodaily

The new Cancer Grand Challenges teams pushing the frontiers of science

7 days / cancerresearchuk / Tim Gunn

Saturday, March 7, 2026, 11:22 am / permalink 20326 / 67 stories in 3 days


CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance / OncoDaily

oncodaily - ALRCaN presents “CART19-BE-02 trial: From Bench to Bedside and Beyond—Implementing a Hospital-Based CAR T Program and Integrating It into the Spanish NHS” with Dr. Valentín Ortiz-Maldonado. “Dear friends and colleagues, […]

#healthcare #publichealth #governmentpolicy #healthcarefinance #infectiousdisease

'I'm still haunted that he died alone': The last voices of the Covid inquiry

5 days / bbc

CART19-BE-02 trial: From Bench to Bedside and Beyond – Resonance

5 days / oncodaily

Covid inquiry chair defends £200m cost and four-year process on final day

5 days / bbc

Covid inquiry chair defends £200m cost and four-year process on final day

5 days / bbc

Saturday, March 7, 2026, 2:22 am / permalink 20317 / 4 stories in 4 days


Telehealth growth hasn’t increased rural behavioral healthcare access: Study / Beckers

Giles Bruce / beckershospitalreview - The rise in telemedicine over the past several years hasn’t translated to more behavioral healthcare access in rural areas, according to a March 5 study in JAMA Network Open. Researchers from Boston-based Harvard Medical School and Providence, R.I.-based …

#healthcare #publichealth #governmentpolicy #digitalhealth #behavioralhealth #healthcarefinance

Why UHS Is Acquiring Talkspace for $835M

17 hrs / medcitynews / Marissa Plescia

Doubling of new prescriptions for ADHD medications among adults since start of COVID-19 pandemic

2 days / medicalxpress

Virtual-First Care Shouldn’t Spark an “A-Ha” Moment Anymore

3 days / medcitynews / Michael Dalton

Telehealth growth hasn’t increased rural behavioral healthcare access: Study

4 days / beckershospitalreview / Giles Bruce

Study finds telemedicine surge barely changed rural mental health access

6 days / medicalxpress

Saturday, March 7, 2026, 1:22 am / permalink 20316 / 5 stories in 4 days


New FDA bonus pilot to address 'workforce challenges' / Endpoints

Max Bayer / endpoints - A new bonus pilot program meant to reward fast-working FDA reviewers will be funded in part by money from industry user fees, the first details on how Commissioner Marty Makary plans to finance the incentive ...

#healthcare #pharmaceuticals #governmentpolicy #biotech #drugdevelopment #fda #healthcarefinance

New FDA bonus pilot to address 'workforce challenges'

5 days / endpoints / Max Bayer

FDA to offer cash bonuses for faster drug reviews

8 days / medicalxpress

Saturday, March 7, 2026, 12:23 am / permalink 20312 / 2 stories in 4 days


Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC / Healthcare Dive

Rebecca Pifer Parduhn / healthcaredive - It’s looking increasingly likely that the UnitedHealth and CVS drug middlemen will also make peace with federal regulators, after Cigna agreed to a sweeping settlement in the insulin lawsuit last month.

#healthcare #pharmaceuticals #drugpricing #publichealth #governmentpolicy #healthcarefinance

It Took Years for Congress to Enact PBM Transparency, Delinking. What About Vertical Integration?

2 days / medcitynews / Marissa Plescia

FTC seeing 'progress' in discussions with Optum, Caremark in insulin case

5 days / fiercehealthcare

Optum Rx, Caremark making ‘significant progress’ in settlement talks with FTC

6 days / healthcaredive / Rebecca Pifer Parduhn

Saturday, March 7, 2026, 12:23 am / permalink 20308 / 3 stories in 4 days


Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology / MedCity

Frank Vinluan / medcitynews - Under the settlement, Genevant Sciences and Arbutus Biopharma will grant Moderna a non-exclusive license to their lipid nanoparticle technology for mRNA delivery in infectious disease vaccines. If Moderna’s full financial payout to the companies is reache…

#healthcare #pharmaceuticals #publichealth #biotech #drugdevelopment #healthcarefinance #infectiousdisease

Hung Trinh: Moderna Reaches $2.25B Settlement in mRNA Vaccine Patent Dispute

4 days / oncodaily

Moderna to Pay Up to $2.25B to Settle Patent Suit Over Covid-19 Vaccine Technology

6 days / medcitynews / Frank Vinluan

Moderna will pay $950M to settle Covid vaccine patent claims with Arbutus, Roivant

7 days / endpoints / Nicole DeFeudis

Saturday, March 7, 2026, 12:22 am / permalink 20307 / 3 stories in 4 days


Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma / MedCity

Frank Vinluan / medcitynews - Day One Biopharmaceuticals is Servier’s biggest acquisition yet, topping the $2.4 billion it paid to buy Shire’s cancer business in 2018. Day One markets Ojemda, approved for treating pediatric low-grade glioma, the most common type of brain cancer in chi…

#healthcare #pharmaceuticals #biotech #mergersandacquisitions #drugdevelopment #oncology #healthcarefinance

Agreement with Day One Biopharmaceuticals to Expand Glioma Portfolio – Servier

3 days / oncodaily

Servier: A Caregiver’s Powerful Story on Rare Disease

4 days / oncodaily

Servier Boosts Presence in Rare Cancers With $2.5B Acquisition of Day One Biopharma

4 days / medcitynews / Frank Vinluan

Servier to buy Day One for $2.5B, gaining rare oncology medicines

5 days / endpoints / Kyle LaHucik

Saturday, March 7, 2026, 12:22 am / permalink 20306 / 4 stories in 4 days


Back to Top


HEALTHCAREFINANCE Heatmap

90 days, weeks are vertical, left is older; hover for info, click to see that day's coverage.



More Top Stories...

FDA refuses to review Moderna mRNA flu vaccine application

Moderna’s mRNA flu vaccine application has been rejected by the FDA—Moderna received a refusal‐to‐file letter while accusing the agency of shifting its review standards. Multiple reports echo this regulatory setback, fueling industry concerns over consistent, transparent decision‐making. More...


FDA CRL halts AstraZeneca’s Saphnelo prefilled pen approval

AstraZeneca’s application to market its subcutaneous prefilled pen formulation of Saphnelo for treating lupus has hit a roadblock after the FDA issued a complete response letter. The decision delays the drug’s approval and raises questions about its future in the competitive immunotherapy market. More...


CMS proposes sweeping changes to ACA marketplace plan rules

CMS has proposed a major rule reshaping Affordable Care Act marketplace policies, including loosening limits on non-standard plan designs and promoting lower-premium options such as catastrophic coverage. The agency says the changes will reduce costs and boost flexibility, while critics warn they could increase confusion and weaken consumer protections—because shopping for insurance clearly wasn’t complicated enough. More...


Tenet forecasts major ACA exchange enrollment drop and financial hit

Tenet Healthcare is warning that the expiration of enhanced Affordable Care Act premium tax credits will drive a steep reduction in ACA exchange enrollment, projecting a significant revenue impact in 2026. Despite the headwind, the company says it expects earnings growth, leaning on acuity and operational performance—because nothing calms Wall Street like “we’ll make it up somewhere else.” More...


City of Hope promotes Nisha Morris to senior marketing chief

City of Hope named Nisha Morris as Senior Vice President and Chief Marketing and Communications Officer, adding marketing leadership to its executive team. The move signals a renewed focus on brand, outreach, and patient engagement as the cancer center sharpens its communication and growth strategies. More...


NorthFeed Inc.

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.